T1	Participants 1285 1372	Of the 200 patients enrolled, 99 were randomized to misoprostol and 101 to dinoprostone
T2	Participants 1678 1762	50 (50.5%) misoprostol-treated patients and 43 (43.5%) dinoprostone-treated patients
